Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: Inner versus outer retina, parafovea versus peripheral fovea

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 5, 2015, Pages 3415-3426

  De Sisternes, Luis ^a   Hu, Julia ^a   Rubin, Daniel L ^a,b   Marmor, Michael F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Hydroxychloroquine retinopathy; Optical coherence tomography; Plaquenil; Progression; Toxicity

Indexed keywords

HYDROXYCHLOROQUINE; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MIDDLE AGED; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; RETINA FOVEA; RETINA INNER PLEXIFORM LAYER; RETINA OUTER PLEXIFORM LAYER; RETINA PARAFOVEA; RETINA PERIPHERALFOVEA; RETINAL THICKNESS; RETINOPATHY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TOPOGRAPHY; CHEMICALLY INDUCED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA DISEASE;

ADULT; AGED; ANTIMALARIALS; ANTIRHEUMATIC AGENTS; FEMALE; FOVEA CENTRALIS; HUMANS; HYDROXYCHLOROQUINE; MALE; MIDDLE AGED; RETINAL DISEASES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84939864429     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-16345     Document Type: Article

References (15)

1. Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132:1453-1460.
2. Melles RB, Marmor MF. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity. Ophthalmol. 2015;122:110-116.
3. Marmor MF. Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol. 2012;130:461-469.
4. Rosenthal ARR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL. Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci. 1978;17:1158-1175.
5. Marmor MF, Hu J. Effect of disease stage on progression of hydroxychloroquine retinopathy. JAMA Ophthalmol. 2014; 132:1105-1112.
6. Pasadhika S, Fishman GA. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye. 2010;24:340-346.
7. Pasadhika S, Fishman GA, Choi D, Shahidi M. Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine toxicity. Eye. 2010;24:756-762.
8. Ulviye Y, Betul T, Nur TH, Selda C. Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine. Indian J Ophthalmol. 2013;61:168-171.
9. Lujan BJ, Roorda A, Knighton RW, Carroll J. Revealing Henle’s fiber layer using spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52:1486-1492.
10. Ouyang Y, Walsh AC, Keane PA, Heussen FM, Pappuru RK, Sadda SR. Different phenotypes of the appearance ofthe outer plexiform layer on optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2013;10:2311-2317.
11. Mwanza JC, Durbin MK, Budenz DL, et al. Glaucoma diagnostic accuracy of ganglion cell-inner plexiform layer thickness: comparison with nerve fiber layer and optic nerve head. Ophthalmol. 2012;119:1151-1158.
12. Lee MG, Kim SJ, Ham DI, et al. Macular retinal ganglion cellinner plexiform layer thickness in patients on hydroxychlor-oquine therapy. Invest Ophthalmol Vis Sci. 2014;56:396-402.
13. Marmor MF, Kellner U, Lai TY, et al. American Academy of Ophthalmology Update Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmol. 2011;118:415-422.
14. de Sisternes L, Simon N, Tibshirani R, Leng T, Rubin DL. Quantitative SD-OCT imaging biomarkers as indicators of age-related macular degeneration progression. Invest Ophthalmol Vis Sci. 2014;55:7093-7103.
15. Hartigan JA, Wong MA. A K-means clustering algorithm. JR Stat Soc Series C. 1979;28:100-108.